Blog

Opioid-related deaths in Ontario remain persistently high, driven largely by an unstable and unregulated drug supply. In response, harm reduction services, such as supervised consumption sites/consumption and treatment services and safer supply programs, have been implemented to reduce the risks of overdose and connect people who use drugs with essential healthcare and social services.

Last week, the Ministry of Health quietly marked a historic milestone: it granted a license to Christchurch-based psychiatrist Professor Cameron Lacey to prescribe psilocybin for treatment-resistant depression. This is the first time the psychedelic compound will be legally prescribed in New Zealand outside of a clinical trial.

This article discusses how unintended side effects from the international regime of drug criminalization may serve to increase harmful drug use among some population segments and performs systematic scoping reviews of two putative underlying dynamics relating to violence victimization and the forbidden fruit or psychological reactance effect.

Drug legislation has never been a neutral or purely scientific matter of public health or criminal justice. Rather, drug laws have long functioned as mechanisms of social control deeply embedded in racialised and colonial systems of domination.

London Drugs Commission (LDC) has released its report on cannabis policy, offering a pragmatic middle ground between full legalisation and the failed status quo of prohibition. While some advocates may argue the recommendations don’t go far enough, this report represents a critical step in the right direction—one that deserves support

Although there is growing support for the protective effects of psychedelics on mental health, recent evidence finds racial and ethnic minorities gain fewer benefits.

Last week, the Ukrainian Ministry of Health took an important step toward enabling scientific research with psychedelics.

The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4-methylenedioxymethamphetamine (MDMA)

This paper delves into the crucial yet complex relationship between federal laws and scientific research, centering on the Controlled Substa

Average pill strength has increased in 2024, back to pre-pandemic levels

On June 6, 2024, the Dutch State Committee MDMA presented its report entitled “MDMA: Beyond ecstasy” to the Dutch Minister of Medical Care.

The Therapeutic Goods Administration (TGA) in Australia recently made a groundbreaking decision to reschedule two drugs as treatments for ce

Authors Alex Stevens, Niamh Eastwood and Kirstie Douse Published March 24, 2024 Abstract In this review article, we develop the case for...

Authors Torsten Passie Published February 22, 2024 Abstract The emergence of a so-called psychedelic renaissance has been proposed to...

Key take-home messages: The disposable vape ban is intended to curb youth vaping, addressing the increasing use of vaping among youth in...

Over time there has been an increase in access to medicine, leading to the bulk of drugs becoming unused and being kept at home.

All images used in this blog are owned by The Loop Written by – Professor Fiona Measham Founder and Chair of The Loop Chair in...

Minorities’ diminished psychedelic returns: Cardio-metabolic health. Race differences remain a critically understudied gap in psychedelic li

Terminal patients are calling for compassionate access to be granted for psilocybin — the psychedelic substance found in fungi known as ‘mag

Read our latest report on why patients experiencing 'Existential Distress' ought to be permitted access to psilocybin-assisted psychotherap

The exact number of drug-related deaths at UK music festivals in recent years is unknown, and there are no standard processes for reporting